Metraipolis › archive › dc_3e9dfa412d42
Comprehensive management of chest wall recurrent HER2-positive breast cancer with Anlotinib and hypofractionated radiotherapy: a case report — Europe PMC PMID:41561735
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41561735
- DOI
- 10.3389/fonc.2025.1708884
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T01:38:24.330Z
- SHA-256 of the archived text
b0d44589fdb0385f1645f4b92f202ea127fdeacca3a5012faf34ddf8e0a933fc- Stable URL of this page
https://metraipolis.com/documento/dc_3e9dfa412d42
How to cite
Comprehensive management of chest wall recurrent HER2-positive breast cancer with Anlotinib and hypofractionated radiotherapy: a case report — Europe PMC PMID:41561735 — Europe PMC (en), https://europepmc.org/article/MED/41561735 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3e9dfa412d42 (Metraipolis archive dc_3e9dfa412d42, sha256 b0d44589fdb0385f1645f4b92f202ea127fdeacca3a5012faf34ddf8e0a933fc)
BibTeX
@misc{dc3e9dfa412d42,
title = {Comprehensive management of chest wall recurrent HER2-positive breast cancer with Anlotinib and hypofractionated radiotherapy: a case report — Europe PMC PMID:41561735},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41561735},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3e9dfa412d42; sha256 b0d44589fdb0385f1645f4b92f202ea127fdeacca3a5012faf34ddf8e0a933fc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41561735. Agents can read the archived copy with the MCP tool read_document.